COMPANY

Cue Biopharma

HQ: Somerville, MA source · cuebiopharma.com ↗ · New England

Keywords: immunology autoimmune diseases

Location: Somerville, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Jul 9, 2026 Raise Private placement: $50M (total, as published), announced Jul 9, 2026. Source: SEC filing. source ↗ · Form D filed Jul 22, 2026 SEC Form D ↗
Apr 30, 2026 Raise Private placement: $30M (total, as published), announced Apr 30, 2026. Source: SEC filing. source ↗ · Form D filed May 14, 2026 SEC Form D ↗
Apr 30, 2026 Partnership Partnership / licensing: upfront $15M paid by the company to the licensor (in-licensing; not money received), announced Apr 30, 2026. Source: SEC filing. source ↗
Dec 19, 2025 Raise Follow-on offering: $10M (total, as published), announced Dec 19, 2025. Source: SEC filing. source ↗
Nov 6, 2025 Partnership Partnership / licensing announced Nov 6, 2025. Source: SEC filing. source ↗
Apr 14, 2025 Raise Follow-on offering: $20M (total, as published), announced Apr 14, 2025. Source: SEC filing. source ↗

Raised: $110.0M. Last 2 years.

Jul 9, 2026 Private placement: $50M (total, as published), announced Jul 9, 2026. Source: SEC filing. source ↗ · Form D filed Jul 22, 2026 SEC Form D ↗
Apr 30, 2026 Private placement: $30M (total, as published), announced Apr 30, 2026. Source: SEC filing. source ↗ · Form D filed May 14, 2026 SEC Form D ↗
Dec 19, 2025 Follow-on offering: $10M (total, as published), announced Dec 19, 2025. Source: SEC filing. source ↗
Apr 14, 2025 Follow-on offering: $20M (total, as published), announced Apr 14, 2025. Source: SEC filing. source ↗
Apr 30, 2026 Partnership / licensing: upfront $15M paid by the company to the licensor (in-licensing; not money received), announced Apr 30, 2026. Source: SEC filing. source ↗
Nov 6, 2025 Partnership / licensing announced Nov 6, 2025. Source: SEC filing. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2026-07-22 Raise Private raise (SEC Form D): $50.0M sold; issuer “Cue Biopharma, Inc.”. Verified from the SEC filing. SEC filing ↗
2026-05-14 Raise Private raise (SEC Form D): $30.0M sold; issuer “Cue Biopharma, Inc.”. Verified from the SEC filing. SEC filing ↗